Skip to main content

Advertisement

Peer Review reports

From: Plasmalemmal Vesicle Associated Protein (PLVAP) as a therapeutic target for treatment of hepatocellular carcinoma

Original Submission
16 Apr 2014 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
21 Apr 2014 Author responded Author comments - Kuo-Jang Kao
Resubmission - Version 5
21 Apr 2014 Submitted Manuscript version 5
13 Jun 2014 Reviewed Reviewer Report - Florence Schaffner
15 Jul 2014 Reviewed Reviewer Report - Joseph W.Y. Lau
1 Aug 2014 Reviewed Reviewer Report - Bertino Gaetano
4 Aug 2014 Reviewed Reviewer Report - Chiun Hsu
25 Aug 2014 Author responded Author comments - Kuo-Jang Kao
Resubmission - Version 6
25 Aug 2014 Submitted Manuscript version 6
Resubmission - Version 7
Submitted Manuscript version 7
18 Sep 2014 Reviewed Reviewer Report - Florence Schaffner
15 Oct 2014 Author responded Author comments - Kuo-Jang Kao
Resubmission - Version 8
15 Oct 2014 Submitted Manuscript version 8
15 Oct 2014 Author responded Author comments - Kuo-Jang Kao
Resubmission - Version 9
15 Oct 2014 Submitted Manuscript version 9
23 Oct 2014 Author responded Author comments - Kuo-Jang Kao
Resubmission - Version 10
23 Oct 2014 Submitted Manuscript version 10
Publishing
27 Oct 2014 Editorially accepted
6 Nov 2014 Article published 10.1186/1471-2407-14-815

You can find further information about peer review here.

Back to article page